New Test Might Replace PSA In Prostate Cancer Detection
Gen-Probe has announced today the European commercial launch of its PCA3 assay, a new prostate cancer-specific molecular diagnostic test, at the annual meeting of the British Association of Urological Surgeons Section of Oncology (BAUS). The PCA3 test has been CE marked, allowing it to be marketed in the European Union (EU).